Leqembi Vs. Kisunla: An Alzheimer’s Drug Point-by-Point Comparison
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
The way people living with dementia experience the world can change as the disease progresses. Their sense of reality or place in time can…
By 2050, around 135 million people worldwide will be living with dementia. The most common cause of dementia is Alzheimer’s disease. Women are more…
Would you still participate in an Alzheimer’s clinical trial if you found out that because of your genetics, you were more vulnerable to serious…
Many caregivers struggle with feeling like they need to offer support to their loved one at all times — and still do seemingly the opposite:…
Alzheimer’s disease is a lot more than memory loss. Many people with the disease develop psychiatric problems like agitation — which are hard to…
Light pollution is a growing issue. Over the past 25 years, artificial lighting has surged by 49% worldwide. For perspective, the brightness of the…
In the 1950s, doctors Carlton Gajdusek and Vincent Zigas trekked over mountains and across rivers to study a mysterious and fatal neurological disease called…
Neuroscientists are currently researching how psychedelic drugs like MDMA, LSD, psilocybin, ketamine, and ibogaine reveal how our brains work and, ultimately, if they can…
In 2022, more Canadians died by medical euthanasia than from pneumonia, Alzheimer’s, or liver disease. The Quebec government announced in October that people with…
In many households, screens are part of daily life – from work to entertainment. But for parents, setting boundaries around screens isn’t just about…
Athira Pharma, makers of experimental Alzheimer’s drug fosgonimeton, paid up $4 million to settle a federal case following allegations that the company manipulated scientific…
In addition to warmer, drier, more extreme weather, climate change is also causing more active wildfire seasons, and that means more exposure to wildfire…
A single mild concussion while playing amateur sports does not lead to long-term cognitive decline a recent study has found. This conclusion may seem…